Mesenchymal Stem/Stromal Cell Therapy in the Treatment of Frailty

NCT04919135 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

158

Enrollment

OTHER

Sponsor class

Conditions

Frailty

Interventions

BIOLOGICAL: Umbilical Cord Mesenchymal Stem Cells transplantation
DRUG: standard frailty treatment and supplementary medication

Sponsor

Vinmec Research Institute of Stem Cell and Gene Technology